Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT04846205
Eligibility Criteria:
Inclusion Criteria:
\- Patients who have had a cerebral or retinal infarction confirmed by brain imaging or a defined transient ischemic attack without an identifiable cause after a detailed etiological assessment
Exclusion Criteria:
* Identification of a cause of ischemic stroke:
* Atheromatous stenosis \> 50% (or atherosclerotic plaque \< 50% threatening) of supra aortic trunk or intracranial arteries on echodoppler of the supra aortic trunk and transcranial or scanner angiography.
* Emboligenic heart disease : atrial fibrillation and atrial flutter, thrombus in left atrium, spontaneous contrast in left atrium, decreased atrial flow, left ventricular ejection fraction (LVEF) \< 40%, LV aneurysma, left intraventricular thrombus, recent myocardial infarction, cardiomyopathy ventricular dilated left with LVEF \< 35%, mitral stenosis, prosthetic mitral or aortic valve, infectious and non-infectious endocarditis, valve or mural tumor, complicated aortic arch atheroma (plaque \> = 4 mm, ulcerated plaque, thrombus on plaque), aortic dissection
* Lacunar infarction symptomatic = \< 1.5 cm on the CT scan, = \< 2 cm on the diffusion MRI or the FLAIR.
* No atherosclerotic arteriopathy : dissection, primary and secondary angitis, spastic angiopathy, etc…
* Coagulopathy to come a long-term anticoagulant treatment (\> 6 months) (anti-phospholipid syndrome, thrombophilia).
* Blood disorders and cancer
* Recent intravenous drug use (in the 6 months before the stroke).
* Other potential causes:
* Severe respiratory impairment or pulmonary arterial hypertension
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT04846205
Study Brief:
Protocol Section:
NCT04846205